Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients and pharmaceutical intermediates, cooperative R & D, custom manufacturing, sales and service as well as import of pharmaceutical raw materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic pharmaceutical companies, including pharmaceutical applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provides factory quality management system certification consulting services.
Internationally, we has long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provides API registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
Medtronic
- Although a leading global medical technology company rather than a pure drug importer, its hypertension product line covers blood pressure monitors, drug therapies, and other fields. With a wide global business layout, it imports related antihypertensive drugs.
AbbVie
- As a large multinational pharmaceutical company, it holds a significant position in the global pharmaceutical market, engaging in R&D, production, and sales of antihypertensive drugs. It may import products to supplement its pipeline or meet market demands in different regions.
Johnson & Johnson
- With multiple business divisions, including pharmaceuticals, it has enormous influence in global healthcare. It imports antihypertensive drugs to enrich its product portfolio. Its Janssen Pharmaceutical division has numerous cardiovascular drugs.
Pfizer
- One of the world's largest biopharmaceutical companies, it has various well-known antihypertensive drugs (e.g., amlodipine). With an extensive global sales network, it may also import niche antihypertensive drugs or raw materials from other regions.
AstraZeneca
- A leading global biopharmaceutical enterprise, its hypertension drugs hold a high market share. With multiple antihypertensive drugs sold worldwide, it engages in import activities to optimize supply and market distribution.
Novartis
- A leading global pharmaceutical company, it has a rich portfolio of antihypertensive drugs (e.g., valsartan). Operating globally, it imports and exports drugs based on market demand and strategies.
Sanofi
- A leading global biopharmaceutical enterprise, it has numerous products for cardiovascular disease treatment. Its antihypertensive drugs enjoy a high market share, and its global supply chain involves importing such drugs.
Bayer
- A renowned global pharmaceutical company, its hypertension drugs are highly recognized for stable quality and efficacy. With extensive global sales and import operations, it ensures product supply and market coverage.
Merck & Co.
- Holding an important position in the global pharmaceutical industry, it has various antihypertensive drugs (e.g., losartan), providing treatments to patients in different regions through global sales and import channels.